About Histogen

Histogen is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets based on stimulating the body’s stem cells to regenerate tissues and restore youthful function. The Company’s lead therapeutic product has demonstrated in clinical studies to stimulate hair growth, addressing an underserved, multibillion dollar global market. Further applications of the technology include skincare, orthopedics indications such as cartilage formation and spinal disk repair, wound healing and dermal fillers.


Histogen, Inc., a Delaware Corporation, was founded in 2007 to develop innovative products utilizing the proteins and growth factors produced by cells grown under simulated embryonic conditions. The Company is headquartered in San Diego, California.

Histogen founder Dr. Gail Naughton is a highly respected scientist with extensive experience in the field of tissue engineering and regenerative medicine. Dr. Naughton discovered the potential of proteins and growth factors produced by hypoxia-induced multipotent cells for therapeutic and biomedical applications, and developed Histogen’s unique technology process to create products based on these proteins. The technology is protected by patent families filed in the US and across key geographies.


Our Mission

To redefine regenerative medicine by developing high value therapeutic and aesthetic products that stimulate the body’s own stem cells to regenerate tissues, without the use of embryonic stem cells or animal components.


Histogen’s Executive Management team has decades of experience in bringing cell-based regenerative products from concept to market. In addition, the Company’s Board of Directors and Scientific Advisors are leaders in the fields of regenerative medicine and global marketing and business operations. Histogen has brought on experienced consultants to advise the team in regulatory, quality and production areas.

Board of Directors

Latest News

Recent & Upcoming Events

January 22-25, 2019

World Stem Cell Summit

Miami, FL
Dr. Gail Naughton to present "Mitigating clinical and business risk: standardising manufacturing practice in cell and gene therapies"
March 21, 2019

ARM Cell & Gene Therapy Investor Day

New York, NY
Histogen Chairman & CEO Richard Pascoe to present.


No current openings